# A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

> **NCT00232778** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 579 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** GAMMA-Iridium-192 catheter

## Key facts

- **NCT ID:** NCT00232778
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 579 (—)
- **Last updated:** 2008-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232778, "A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00232778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*